Beginning in mid-February 2008, the 1997-2007 online version of the Science Watch® newsletter, ESI-Topics.com, and in-cites.com, will all be featured together on the redesigned ScienceWatch.com. All previous content from the three sites will be permanently archived, and remain accessible from any existing bookmarks to the archived pages. No new content will be added to this site. Updates and new content (updated biweekly) are available at ScienceWatch.com now.

Fast Breaking Comments

By Bernhard Moser and Pius Loetscher

ESI Special Topics, October 2005
Citing URL - http://www.esi-topics.com/fbp/2005/october05-Moser_Loetscher.html

Bernhard Moser and Pius Loetscher answers a few questions about this month's fast breaking paper in the field of Immunology.


From •>>October 2005

Field: Immunology
Article Title: Chemokines: multiple levels of leukocyte migration control
Authors: Moser, B;Wolf, M;Walz, A;Loetscher, P
Journal: TRENDS IMMUNOL
Volume: 25
Page: 75-84
Year: FEB 2004
* Univ Bern, Theodor Kocher Inst, Freiestr 1, CH-3012 Bern, Switzerland.
* Univ Bern, Theodor Kocher Inst, CH-3012 Bern, Switzerland.
* Novartis Pharma AG, Novartis Inst Biomed Res, CH-4002 Basel, Switzerland.

ST:  Why do you think your paper is highly cited?


“This review article gives a timely update of the development and progress in chemokine research and is focused on the highly competitive area of lymphocyte traffic control.”

This review article gives a timely update of the development and progress in chemokine research and is focused on the highly competitive area of lymphocyte traffic control. It emphasizes the paradigm that predicts an intimate relationship between leukocyte migration properties and leukocyte function. In other words, knowledge about the migration and localization properties of a given type of leukocytes allows us to predict its state of differentiation and function in immune processes. These migration properties are defined by adhesion molecules and chemokines, which form the largest class of cytokines. Chemokines act as chemoattractants by binding to chemokine receptors present on leukocytes. The information in this article is useful to chemokine specialists and those who wish to enter this highly competitive field of research.

ST:  Could you summarize the significance of your paper in layman's terms?

This review article is focused on one aspect in chemokine research, namely the contribution of chemokines to the control of lymphocyte traffic. In essence, chemokines guide lymphocyte placement and relocation in all aspects of adaptive immunity, including lymphopoiesis, initiation of effector lymphocyte generation in lymph nodes and lymphocyte recruitment to sites of inflammation as well as immune surveillance of peripheral tissues. Traffic of effector/memory T cells is discussed in great detail.

ST:  How did you become involved in this research?

We have a long-standing interest in this area of research, dating back to the earliest chemokines that were discovered in the late 1980s. One of our main contributions was the discovery that not only cells of the innate immune system, such as neutrophils and monocytes, but also T lymphocytes of the adaptive immune system are targeted by chemokines. Current research activities are centered on the mechanisms controlling the steady-state traffic of long-lived memory T lymphocytes through secondary lymphoid and non-lymphoid tissues.End

Bernhard Moser, P.D., Ph.D.
Institute of Cell Biology
University of Bern
Bern, Switzerland

Pius Loetscher, P.D., Ph.D. 
Novartis Institutes for BioMedical Research 
Rheumatoid Arthritis
Basel, Switzerland


Read New Hot Paper comments from the above authors for another paper in the field of Immunology. 

ESI Special Topics, October 2005
Citing URL - http://www.esi-topics.com/fbp/2005/october05-Moser_Loetscher.html

•> Search Special Topics
Fast Breaking Papers Menu || All Topics Menu
Fast Breaking Papers Comments Menu
Help || About || Contact

ScienceWatch.com - Tracking Trends and Perfomance in Basic Research
Go to the new ScienceWatch.com

Write to the Webmaster with questions/comments. Terms of Usage.
The Research Services Group of Thomson Scientific |
(c) 2008 The Thomson Corporation.